Locally Delivered Aloe Vera Gel in the Treatment of Chronic Periodontitis Patients With Diabetes Mellitus

Dr. D. Y. Patil Dental College & Hospital15 enrolled

Overview

A study on the effect of locally delivered aloe vera gel as an adjunct to scaling and root planing in the treatment of chronic periodontitis patients with controlled type II diabetes mellitus.The evaluation of Plaque Index, Gingival Index, Probing Pocket Depth, Relative Attachment Level at baseline, 6 weeks and 3 months and Glycosylated heamoglobin at baseline and 3 months.

Aloe vera gel was locally delivered in the periodontal pockets of ≥ 5mm bilaterally in chronic periodontitis patients with diabetes under control.(HbA1c-6.6-8.6%).The study design had two groups-one in which scaling and root planing and local delivery of aloe vera gel and the other only scaling and root planing. The evaluation of clinical parameters of PI, GI, PPD and RAL at baseline, 6 weeks and 3 months. HbA1c evaluated at baseline and 3 months.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Diabetes Mellitus Chronic Periodontitis

Interventions

SRP + AloeDRUG

Scaling and root planing along with aloe vera application was done

SRPPROCEDURE

Scaling and root planing was done

Eligibility

Sex: ALLMin age: 30 YearsMax age: 55 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients age 30 - 55 years from both genders. 2. Patients with controlled Type II Diabetes Mellitus (HbA1c \< 7%) with Chronic periodontitis having ≥ 5mm periodontal pockets bilaterally atleast in one site. 3. Patients on oral hypoglycaemic agents. 4. Subjects who have not received periodontal therapy within preceding 6 months. 5. Patients willing to comply with all study related procedures. Exclusion Criteria: 1. Subjects who have received antibiotic treatment in the preceding 3 months. 2. History of prolonged use of antibiotics/ steroids/ immunosuppressive agents /aspirin/ anticoagulants/ other medications including any other herbal products. 3. Pregnant or lactating women. 4. Smokers. 5. History of systemic diseases like hypertension, HIV, bone metabolic disorders, radiation therapy, Osteoporosis, immunosuppressive therapy, cancer etc.other than Diabetes. 6. Unwilling patients

Outcomes

Primary Outcomes

Clinical parameter of probing pocket depth

Clinically change in the probing pocket depth.

Time frame: 3 months

Secondary Outcomes

Glycosylated haemoglobin

HbA1c levels evaluated at baseline and 3 months

Time frame: 3 months

Clinical parameter of plaque index

Change in the plaque index.

Time frame: 3 months

Clinical parameter of gingival index

Change in the gingival index.

Time frame: 3 months

Clinical parameter of relative attachment level

Change in the relative attachment level.

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.